YanYanZhou Faculty Profile

YanYan  Zhou

Professor

  • University of MarylandYale School of Management
  • Spring Semester 2026

    Course #SecCourse TitleDaysFromToLocationCampus
    STAT 3101AStatistics for Social SciencesW10:00AM11:40AMSC-N206Hayward Campus
    STAT 31002Statistics for Social SciencesM12:00PM1:40PMSC-N206Hayward Campus
    STAT 30301Statistical Methods in BiologyM4:00PM5:40PMAE-0253Hayward Campus
    STAT 3031AStatistical Methods in BiologyW4:00PM5:40PMAE-0253Hayward Campus
    STAT 33101Intro to ANOVAMW2:00PM3:15PMSC-N206Hayward Campus
    STAT 31001Statistics for Social SciencesM10:00AM11:40AMSC-N206Hayward Campus
    STAT 3102AStatistics for Social SciencesW12:00PM1:40PMSC-N206Hayward Campus
    • Sharifian, Igland, KlungsøyrEngeland, Zhouand Bjørge (2024). Incidence trends of adult glioma in Norway and its association with occupation and education: A registry-based cohort study. Cancer Epidemiology, Volume 89, 102524.
    • Hegvik, Zhou, Brauckhoff, Furu, Hjellvik, Bjørge, and Engeland (2024). Prevalence of drugs used for chronic conditions after diagnosis of thyroid cancer: a register-based cohort study. European Journal of Endocrinology, Volume 191, Issue 2, Pages 166–174. 
    • Roschangar, Li, Zhou, Aelterman, Borovika, Colberg, Dickson, Gallou, Hayler, Koenig, Kopach, Kosjek, Leahy, O’Brien, Smith, Henry, Anastasp, and Sheldonr (2022). Improved iGAL 2.0 Metric Empowers Pharmaceutical Scientists to Make Meaningful Contributions to United Nations Sustainable Development Goal. ACS Sustainable Chemistry & Engineering, 10, 16, pages 5148–5162.
    • Riddell, Patel, Collins, Zhou, Schramek, Kremer, and Ferron-Brady(2020). An Adaptive Physiologically Based Pharmacokinetic–Driven Design to Investigate the Effect of Itraconazole and Rifampicin on the Pharmacokinetics of Molibresib in Healthy Female Volunteers. The Journal of Clinical Pharmacology. DOI: 10.1002/jcph.1711
    • Roschangar, Zhou, +25 authors, and Senanayake. Inspiring process innovation via an improved green manufacturing metric: iGAL(2018). Green Chemistry 20(10) DOI:10.1039/C8GC00616D.
    • Spink, Anderson + 12 authors, and Zhou(2017). Peak Heart Rate during the 6-Minute Walk Test Predicts Cognitive Performance of Healthy Older Adults. Medicine & Science in Sports & Exercise 49(5S):215
    • Sherwood, Inouye, Anderson, Jordan, Medina, Rueda, Spink, Tabera,; Webb, and Zhou(2016). 6-Minute Walk Test: Relationship To Cognitive Function In Healthy Older Adults. Medicine & Science in Sports & Exercise:  V48(5S):  p 31-32
    • Patnaik, Tolcher, Papadopoulos, Beeram, Rasco, Werner,  Bauman,  Scheuber, Cox,  Patel,  Zhou,  Hamid, Schramek & Sharma(2016).  Phase 1 study to evaluate the effect of the MEK inhibitor trametinib on cardiac repolarization in patients with solid tumours. Cancer Chemotherapy and Pharmacology, volume 78: 491–500.
    • Dukhovny and Zhou (2016). Effects of Icon Size and Location on Speed and Accuracy of SGD Access. Augmentative and Alternative Communication. 2016 Dec; 32(4):241-248.
    • Patnaik, A., Tolcher, A., Papadopoulos, K., Beeram, M., Rasco, D., Werner, T. L., Bauman, J. W., Scheuber, A., Cox, D., Patel, B. R., Zhou,Y.,  Hamid, M., Schramek, D.  and Sharma, S. (2016). Phase I study to evaluate the effect of the MEK inhibitor trametinib on cardiac repolarization in patients with solid tumors. Cancer Chemother Pharmaco 2016 Sep;78(3):491-500.
    • Zhou (2015). Power Transformation for Enhancing Responsiveness of Quality of Life Questionnaire. Springerplus, Volume 4, Issue 1. doi:10.1186/s40064-015-1296-9
    • Zhang, JP., Erickson-Miller, C., Chan, G. and Zhou, Y. (2015). Investigating Effects of Cyclosporine on Eltrombopag Pharmacokinetics in Healthy Volunteers - A Phase 1 Crossover, Drug-drug Interaction Study. 2015 126:4791
    • Patton WN, Lindeman R, Butler AC, Kipps TJ, Jewell RC, Laubscher KH, Zhou Y, Lewis E, Sedoti D, Witman P, Fang L, Chan G. (2015). An open-label, single-arm, phase 1 study to assess biomarker effects, efficacy, and safety of ofatumumab in patients with refractory chronic lymphocytic leukemia. Leukemia and Lymphoma. 2015 Feb 26:1-23
    • Donna C., Alicia A., Zhou, Infante J.R., Gordon M., Bendell J., Jones S., Burris H., and Orford K(2014), Bioavailability of Trametinib Tablet Formulation and the Pediatric Oral Solution in adults with Solid Tumors. Clinical Pharmacology in Drug Development. The American College of Clinical Pharmacology, doi: 10.1002/cpdd.152
    • Paltiel D.A., Ingvarsson E., Lee D., Leff R., Nowak R., Petschke K., Shubik S., Zhou , Shubik M. and O’Connor K(2014). Demographic and clinical features of inclusion body myositis: a cross-sectional, self-reporting survey of 916 patients in North America. Muscle and Nerve. 2014 Dec 30. doi: 10.1002/mus.24562
    • Multiple Facets of Compassion: The Impact of Social Dominance Orientation and Economic Systems Justification(2014). Martin D., Seppala E., Heineberg Y., Rossomando T., Doty J., Zimbardo P., Shiue T., Berger R., and Zhou Journal of Business Ethics. March 2014 , doi: 10.1007/s10551-014-2157-0
    • Makuch, R and Zhou, Y (2011). Issues in the Design, Conduct, and Analysis of Clinical Trials, Epidemiology and Biostatistics, International Prevention Research Institute.
    • Xia J., Mi, J. and Zhou, Y. (2009), On the Existence and Uniqueness of the Maximum Likelihood Estimators of Normal and Lognormal Population Parameters with Grouped Data, Journal of Probability and Statistics, Volume 2009, Article ID 310575, doi:10.1155/2009/310575.
    • Roy, A., Fuller, W. A. and Zhou, Y. (2008), A Likelihood-Based Estimator for Vector Autoregressive Processes, Statistical Methodology, Volume 6, Issue 3, Pages 304-319.
    • Mi, J., Shi, W. and Zhou, Y. (2008) Distributions of Sum And Difference of Independent Pascal Random Variables, Statistics & Probability Letters, 78, p2378-2387.
    • Berger, V., S. Zhang and Zhou, Y. (2007) Further Thoughts on Extrapolation, with Application to Clinical Trials, Statisica Sinica.
    • Zhou, Y., Mi, J. and Guo, S. (2007) Estimation of Parameters in Logistic and Log-logistic Distribution with Grouped data, Lifetime Data Analysis, 13, p421-429.
    • Berger, V., Stefanescu, C. and Zhou, Y. (2006) The Analysis of Stratified 2 x 2 Contingency Tables, The Biometrical Journal, 48, p1-16.
    • Zhou, Y. and Roy, A. (2006). Effect of Tapering on Accuracy of Forecasts Made With Stable Estimators of Vector Autoregressive Processes. International Journal of Forecasting, 22, p169-180.
    • Mi, J., Chen, Z. and Zhou, Y. (2006) Estimating the Mean of Exponential Distribution From Step-Stress Life Test Data, Ch. 19 of Advances on Distribution Theory, Order Statistics and Inference, Birkhauser Boston, Inc.
    • Bergman, A., Stevens, C., Zhou, Y., and Herman, G. (2006) MK-0431 Potently Inhibits Dipeptidyl Peptidase-IV Activity and Increase GLP-1 without Producing Hypoglycemia in Young Healthy Males Results of a Multiple-Dose, Double-Blind, Randomized, Placebo-Controlled Study. Clinical Therapeutics, 28, p55-72.
    • Berger, V., Zhou, Y., Ivanova A. and Tremmel L. (2003) Adjusting for baseline covariates by inducing a partial ordering: issues to consider. The Biometrical Journal, 46, P48-55.
    • Zhou, Y. and Xu, L. (2003) An application of shrinkage estimation to current China's economy", Statistics and Decision, China, September issue, p54-63.
    • Xu, L., Ni, Z. and Zhou, Y. (2003), Scope and restrictiveness of  financial holding company regulation, Urban Finance, China, September issue, p20-25.
    • Xu, L. and Zhou, Y. (2003), Trade modes in the fair stimulated growth, Modern Economic Science, China, December issue. p34-37.

  • 2010 Joint Statistical Meetings, Vancouver.
    A Review of Issues Involving Non-inferiority Trials, with Makuch R.
    2009 Joint Statistical Meetings, Denver.
    Power Transformation for Enhancing Responsiveness of Quality of Life Questionnaire
    2008 Eisai pharmaceuticals, NJ.
    Designs in Phase I Clinical Trials
    2008 University of Maryland, MD.
    Estimation of Parameters in Logistic and Log-logistic Distribution with Grouped data
    2007 California Polytechnic State University, CA.
    Adjusting for Baseline Covariates when Measurements are Ordered Categories
    2006 62nd Deming Conference, Atlantic City, NJ.
    Clinical Trial Design and Permutation Tests
    2006 National Institute of Health, Rockville, MD.
    Adjusting for Baseline Covariates by Inducing a Partial Ordering
    2006 Henry Stewart Talks, Russell House, London.
    Overview of Permutation Tests
    2004 Genetech, San Francisco, CA.
    2003 The International Biometric Society/Eastern North American Region (ENAR), Tampa, FL.
    2002 George Washington University, Washington DC.
    2002 Eli Lilly and Company, Indianapolis, IN.
    2001 National Cancer Institute (NCI), Bethesda, MD. 2001